Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the effect of once-weekly dosing of two dose levels of subcutaneous semaglutide (0.5 mg and 1.0 mg) versus once-weekly dosing of two dose levels of subcutaneous dulaglutide (0.75 mg and 1.5 mg) on glycaemic control in subjects with type 2 diabetes on a background treatment with metformin.
Critère d'inclusion
- Diabetes Mellitus, Type 2